Beta-2 microglobulin: Difference between revisions

From Proteopedia
Jump to navigationJump to search
Michal Harel (talk | contribs)
No edit summary
Michal Harel (talk | contribs)
No edit summary
 
(61 intermediate revisions by 4 users not shown)
Line 1: Line 1:
{{STRUCTURE_3bev|  PDB=3bev  | SIZE=400| SCENE=Cadherin/Cv/1 |right|CAPTION=Human β-2 microglobulin complex with MHC I and HCMV PP65 nonapeptide, [[3bev]] }}
<StructureSection load='' size='350' side='right' scene='45/459284/Cv/1' caption='Human β-2 microglobulin (green) complex with MHC I (magenta) and HCMV PP65 nonapeptide (cyan), [[3mrb]]'>
[[Beta-2 microglobulin]] ('''B2M''') is a component of MHC class I system.  B2M associates with MHC class I α chain, CD1 and Qa.  Loss of B2M function causes iron excess. <ref>PMID:21131979</ref> For more details, see: [[Human beta two microglobulin]] and [[Molecular playground/beta 2 microglobulin]].
<br/>
[[Image:MHC Class 1.png|thumb|200px|left|Diagram of MHC I Complex]]
{{Clear}}
== Disease ==


'''Beta-2 microglobulin''' (B2M) is a component of MHC class I system.  B2M associates with MHC class I α chain, CD1 and Qa.  Loss of B2M function causes iron excess.
Elevated B2M levels are found in patients of liver cirrhosis<ref>PMID:3884477</ref> and hepatitis<ref>PMID:29221492</ref>.  Dialysis-associated amyloidosis is a serious complication in chronic dialysis patients.  It is caused by B2M fibrils amyloid deposits<ref>PMID:10737162</ref>.


{{TOC limit|limit=2}}
== Relevance ==
 
B2M is used as a marker for certain types of blood cell cancer.  It can indicate the spread and severity of myeloma.
 
== Structural Highlights ==
<scene name='45/459284/Cv/2'>Human β-2 microglobulin with MHC class I HLA-A2 and HCMV PP65 nonapeptide</scene> ([[3mrb]]).


== 3D Structures of β-2 microglobulin ==
== 3D Structures of β-2 microglobulin ==
[[Beta-2 microglobulin 3D structures]]
</StructureSection>
== References ==
<references/>




[[Category:Topic Page]]
[[Category:Topic Page]]